Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
Check out the latest issue of the FDA Patient Network Newsletter and sign up for FDA information https://t.co/aigsuJODIw https://t.co/zWkU8gpI3l
SteveFDA (R-D.C.)
@SGottliebFDA
@daviesbj @DShaywitz @anobelodisho @AkikoaCom @Farzad_MD @WholeFoods Drs. @DShaywitz @Farzad_MD @daviesbj et. al. - In consideration of @daviesbj’s recipie (portions highlighted below) I provide a link to #FDA’s recommendations on added salt https://t.co/
SteveFDA (R-D.C.)
@SGottliebFDA
Today @SecAzar speaking at the @NatlGovsAssoc on the commitment of @HHSGov to support those confronting opioid addiction and his commitment to #FDA’s mission to develop safe and effective medical therapy to help people seeking lives free from addiction ht
SteveFDA (R-D.C.)
@SGottliebFDA
As part of #FDA’s 2019 budget we’re investing in an expansion of continuous manufacturing by drug makers to domesticate U.S. production; ensure reliability of supply; reduce shortages; make it easier to respond to crises like flu with rapid vaccine scale
SteveFDA (R-D.C.)
@SGottliebFDA
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_ORA: #MostWantedMonday Stephen Mark Van Rooyen is wanted by #FDAORA #OCI for selling #stemcells & stem cell injections i… https://t.co/tu5VppTUyh
SteveFDA (R-D.C.)
@SGottliebFDA
Ending an “addiction” is separate from achieving “total abstinence”. Someone may be on lifelong replacement therapy with an approved opioid agonist; but no longer be “addicted” to opioids. Psychological addiction is not synonymous with physical dependence
SteveFDA (R-D.C.)
@SGottliebFDA
My statement on what #FDA is learning about the efficacy of this year’s #flu vaccine; and the agency’s ongoing efforts to apply these findings to help improve the effectiveness of future influenza vaccines: https://t.co/NNpr8eBO1l https://t.co/zV6xWQzmyb
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA announced a new orphan drug pilot that will include a new form intended to make the submission process easier for sponsors to complete orphan designation requests, and to make the process more efficient for FDA https://t.co/hnBw9Zqh6c
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA Commissioner @SGottliebFDA re: new steps we’re taking to meet the challenges of rare diseases. #rarediseaseday… https://t.co/7hTGwebPBX
SteveFDA (R-D.C.)
@SGottliebFDA
I’m pleased to announce new @US_FDA efforts to support rare disease therapies #rarediseaseday: https://t.co/qqP2ibvwn7
SteveFDA (R-D.C.)
@SGottliebFDA
At a May 9th meeting on drugs that treat rare cancers; we'll discuss cancer therapies that target a tumor’s specific genetic features rather than its location in body (tissue agnostic approvals) and how we treat these products under the orphan drug progra
SteveFDA (R-D.C.)
@SGottliebFDA
My update today on what #FDA is learning about the potential root cause for why this year’s #flu vaccine showed diminished efficacy against the season’s predominant H3N2 strain of influenza https://t.co/NNpr8eBO1l https://t.co/134Khj6ZAM
SteveFDA (R-D.C.)
@SGottliebFDA
RT @sjtribble: FDA's @SGottliebFDA announces a new pilot, a public meeting, and a memorandum of understanding w/ @RareDiseases as… https://t.co/V55pkUFD7v
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is using what it’s learning about the potential root cause for why this year’s #flu vaccine showed diminished efficacy against the season’s H3N2 strain of flu to prepare for next season and improve vaccine development https://t.co/Sbxx3fN1eH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: .@US_FDA to Launch New Pilot Program for Orphan Designation Requests | #Regulatory Focus https://t.co/zOXAFxQYVD… https://t.co/1pDMWpMXrb
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: We have developed a series of new videos and other materials that explain the scope of what FDA is doing to encoura… https://t.co/8J6k8O3YYE
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: .@FDAOncology perspective: Evaluating Endpoints & Evidence in Era of Breakthrough Therapies @OncJournal https://t.co/NuD9lM1qoz
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: .@US_FDA Considers a Shift on #MedDevice Quality System Regulations | #Regulatory Focus https://t.co/CVE4btXaEv #FDA https://t.co/IrNNIJ8dlX
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is working to improve #flu vaccine efficacy ; find the root cause of this year’s diminished effectiveness against H3N2 https://t.co/pQtJm97apc